Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae
26 August 2022 (13:15 - 13:30)
Organised by:
About the speaker
University Hospital Regensburg, Regensburg (Germany)
3 More presentations in this session
Doctor S. Yamada (Tokyo, JP)
Doctor O. Inoue (Kanazawa, JP)
Access the full session
The Event
ESC Congress 2022
26 August 2022
13:15 CET
You may be interested in
Congress Session
